Silo Pharma, a publicly traded company in the US, announced its first purchase of RSC tokens

ChainCatcher news, diversified development stage biopharmaceutical and cryptocurrency asset management company Silo Pharma, Inc. (NASDAQ: SILO) announced its first purchase of ResearchCoin (RSC) as an important step in expanding its digital asset management strategy, aiming to capture long-term value from emerging multi-chain opportunities.

RSC is the native token of the decentralized research collaboration platform ResearchHub, which was co-founded by Coinbase CEO Brian Armstrong in 2019. Silo Pharma CEO Eric Weisblum stated, "By acquiring RSC, we are participating in the growing decentralized science (DeSci) movement while also diversifying assets and potential appreciation for our shareholders. Our investment in ResearchCoin highlights our focus on the modernization of research collaboration and our support for blockchain-driven innovation as a pillar of biomedical discovery."